Amgen Inc.
AMGN
279.86
USD+1.96
(+0.71%)Day's range
274.42
282.26
52 wk Range
253.3
346.85
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 25,424,000,000 | 25,979,000,000 | 26,323,000,000 | 28,190,000,000 | 33,424,000,000 | |
| Gross Profit | 19,265,000,000 | 19,525,000,000 | 19,917,000,000 | 19,775,000,000 | 20,566,000,000 | |
| Operating Income | 5,794,000,000 | 6,005,000,000 | 5,335,000,000 | 7,897,000,000 | 7,258,000,000 | |
| Net Income | 7,264,000,000 | 5,893,000,000 | 6,552,000,000 | 6,717,000,000 | 4,090,000,000 | |
| Total Assets | 62,948,000,000 | 61,165,000,000 | 65,121,000,000 | 97,154,000,000 | 91,839,000,000 | |
| Total Current Liabilities | 11,653,000,000 | 12,184,000,000 | 15,687,000,000 | 18,392,000,000 | 23,099,000,000 | |
| Total Equity | 9,409,000,000 | 6,700,000,000 | 3,661,000,000 | 6,232,000,000 | 5,877,000,000 | |
| Free Cash Flow | 9,889,000,000 | 8,381,000,000 | 8,785,000,000 | 7,359,000,000 | 10,394,000,000 | |
| Cash from Operations | 10,497,000,000 | 9,261,000,000 | 9,721,000,000 | 8,471,000,000 | 11,490,000,000 | |
| Cash from Investing | -5,401,000,000 | 733,000,000 | -6,044,000,000 | -26,204,000,000 | -1,046,000,000 | |
| Cash from Financing | -4,867,000,000 | -8,271,000,000 | -4,037,000,000 | 21,048,000,000 | -9,415,000,000 | |
| Net Change in Cash | 229,000,000 | 1,723,000,000 | -360,000,000 | 3,315,000,000 | 1,029,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy